AKT-mediated phosphorylation of downstream targets, including mTOR, GSK, and NF-κB, underscores its vital roles in driving the malignant phenotypes of cancer cells by promoting cell cycle progression, inhibiting apoptosis, and enhancing metabolic reprogramming 42-44. This evidence concerns the gene AKT1 and cancer.